BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21086482)

  • 1. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane.
    Duarte CD; Greferath R; Nicolau C; Lehn JM
    Chembiochem; 2010 Dec; 11(18):2543-8. PubMed ID: 21086482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.
    Kieda C; Greferath R; Crola da Silva C; Fylaktakidou KC; Lehn JM; Nicolau C
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15576-81. PubMed ID: 17028170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin.
    Fylaktakidou KC; Lehn JM; Greferath R; Nicolau C
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1605-8. PubMed ID: 15745806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocytes anion transport and oxidative change in beta-thalassaemias.
    Maria C; Leonardo R; Pietro R; Mario V; Isabella V; Diana T
    Cell Biol Int; 2010 May; 34(6):655-62. PubMed ID: 20450494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
    Biolo A; Greferath R; Siwik DA; Qin F; Valsky E; Fylaktakidou KC; Pothukanuri S; Duarte CD; Schwarz RP; Lehn JM; Nicolau C; Colucci WS
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1926-9. PubMed ID: 19204295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes.
    Görgens C; Guddat S; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1102-7. PubMed ID: 25070041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of nitrite transport in red blood cells by hemoglobin oxygen fractional saturation.
    Vitturi DA; Teng X; Toledo JC; Matalon S; Lancaster JR; Patel RP
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1398-407. PubMed ID: 19286940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined endogenous MR biomarkers to assess changes in tumor oxygenation induced by an allosteric effector of hemoglobin.
    Cao-Pham TT; Tran-Ly-Binh A; Heyerick A; Fillée C; Joudiou N; Gallez B; Jordan BF
    NMR Biomed; 2020 Feb; 33(2):e4181. PubMed ID: 31762121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.
    Tran LB; Cao-Pham TT; Jordan BF; Deschoemaeker S; Heyerick A; Gallez B
    J Cell Mol Med; 2019 Mar; 23(3):1908-1916. PubMed ID: 30575283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.
    Oknińska M; El-Hafny-Rahbi B; Paterek A; Mackiewicz U; Crola-Da Silva C; Brodaczewska K; Mączewski M; Kieda C
    J Cell Mol Med; 2020 Feb; 24(3):2272-2283. PubMed ID: 31957267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permselectivity changes in malaria (Plasmodium falciparum) infected human red blood cell membranes.
    Kutner S; Ginsburg H; Cabantchik ZI
    J Cell Physiol; 1983 Feb; 114(2):245-51. PubMed ID: 6337170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
    Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
    FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric effects in stilbenedisulfonate binding to band 3 protein (AE1).
    Salhany JM
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):1065-96. PubMed ID: 8960781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect.
    Evans BA; Ansari AK; Kamyszek RW; Salvagno M; Welsby J; Fuller M; Welsby I
    Blood Cells Mol Dis; 2021 Mar; 87():102520. PubMed ID: 33242840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (DIDS) and chlorpromazine on NO3- transport via anion exchanger in erythrocytes: inertness of DIDS in whole blood.
    Kubota K; Ishibashi T; Matsubara T; Hori T; Ozaki K; Yamazoe M; Yoshida J; Nishio M; Aizawa Y
    J Pharmacol Sci; 2003 Dec; 93(4):505-8. PubMed ID: 14737025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of carboxyl groups in chloride transport and reversible DIDS binding to band 3 protein in human erythrocytes.
    Janas T; Janas T
    Cell Mol Biol Lett; 2011 Jun; 16(2):342-58. PubMed ID: 21442446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABH antigens as recognition sites for the activation of red blood cell anion exchange by the lectin ulex europaeus agglutinin I.
    Engelmann B
    J Cell Physiol; 1993 Nov; 157(2):403-7. PubMed ID: 7693725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease.
    Papassotiriou I; Kister J; Griffon N; Abraham DJ; Kanavakis E; Traeger-Synodinos J; Stamoulakatou A; Marden MC; Poyart C
    Exp Hematol; 1998 Sep; 26(10):922-6. PubMed ID: 9728926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potential treatment for cardiovascular disease through modulation of hemoglobin oxygen binding curve: Myo-inositol trispyrophosphate (ITPP), from cancer to cardiovascular disease.
    Oknińska M; Mackiewicz U; Zajda K; Kieda C; Mączewski M
    Biomed Pharmacother; 2022 Oct; 154():113544. PubMed ID: 35988421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.